Oceania Healthcare (ASX:OCA, NZE:OCA) said new sales volumes increased 29% and resales volumes rose 6% in the third quarter of the fiscal year compared with the prior-year period, according to Wednesday releases with the Australian and New Zealand bourses.
It is continuing to divest non-core sites and it is establishing a centralized team to support the delivery of long-term savings, expected to be in the range of NZ$10 million to NZ$15 million annually, reflecting the right sizing of support functions in light of divestments.
A NZ$5 million annualized cost right sizing program was completed and benefits from it are expected to be realized from fiscal 2026.
It also completed a refinance of debt facilities on Tuesday, March 4.
The firm's shares rose 6% in early trading on Wednesday on the New Zealand bourse and fell 2% on the Australian bourse.
Price (AUD): $0.60, Change: $-0.010, Percent Change: -1.64%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.